Resumen

APARICIO, Marta et al. COVID-19 associated mucormycosis. A case in Argentina. Medicina (B. Aires) [online]. 2022, vol.82, n.2, pp.304-307. ISSN 0025-7680.

SARS-CoV-2 virus disease presents variable severity. Recently, an increasing report of cases of COVID-19 associated mucormycosis (CAM) has been observed, mainly in patients with diabetes mellitus, diabetic ketoacidosis or under steroids treatment. The highest number of cases have been reported in India, with a prevalence of 0.27 % in hospitalized patients with COVID-19 during year 2020, which implies a 2.1-fold increase in the prevalence of mucormycosis compared to year 2019. Although corticosteroids treatment reduces mortality in patients with severe COVID-19, its prolonged use, in combination with other clinical and immunological factors, could increase the risk of invasive fungal infection. We report a case of CAM in Argentina. This report represents a warning for considering the diagnosis of invasive fungal infection in patients with severe COVID-19.

Palabras clave : Mucormycosis; COVID-19; SARS-CoV-2; Invasive fungal infection.

        · resumen en Español     · texto en Español     · Español ( pdf )